These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 9562776)
1. [Maternal serum screening for Down syndrome and neural tube defects]. van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776 [TBL] [Abstract][Full Text] [Related]
2. [Serum screening of pregnant women for fetal neural tube defects and Down syndrome; initial experiences in The Netherlands]. Beekhuis JR; Mantingh A; de Wolf BT; van Lith JM; Breed AS Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1303-7. PubMed ID: 7688448 [TBL] [Abstract][Full Text] [Related]
3. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
4. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related]
7. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study. Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859 [TBL] [Abstract][Full Text] [Related]
8. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience]. Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380 [TBL] [Abstract][Full Text] [Related]
9. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected? Christiaens GC; Hagenaars AM; Akkerman C; De France HF Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002 [TBL] [Abstract][Full Text] [Related]
11. Prenatal biochemical screening for Down's syndrome and neural tube defects. Wald NJ; Kennard A Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963 [TBL] [Abstract][Full Text] [Related]
12. [Study on key techniques and intervention in reducing birth defects]. Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989 [TBL] [Abstract][Full Text] [Related]
13. [How women cope with the results of maternal serum screening for fetal neural tube defects and Down syndrome]. Kamerbeek LI; Roelofsen EE; Beekhuis JR; Tijmstra T; Mantingh A Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1308-11. PubMed ID: 7688449 [TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
15. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]. Zwahr C; Voss P; Kistner G Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195 [TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [TBL] [Abstract][Full Text] [Related]
17. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection]. Christiansen M; Larsen SO; Nørgaard-Pedersen B Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010 [TBL] [Abstract][Full Text] [Related]
18. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening. Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861 [TBL] [Abstract][Full Text] [Related]
19. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131 [TBL] [Abstract][Full Text] [Related]
20. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]